Evidence map›Paper›PMID 37185386›Full record

ArticleCurrent oncology (Toronto, Ont.)2023

The Relationship between Therapeutic Alliance and Quality of Care in Patients with Advanced Cancer in Spain.

Verónica Velasco-Durántez, Luka Mihic-Góngora, Sara Coca-Membribes, Rocío Galán-Moral, Ana Fernández-Montes, Oscar A Castillo-Trujillo, Elena Sorribes, Alicia Quilez, Laura Puntí-Brun, Paula Jiménez-Fonseca and 1 more

Abstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Verónica Velasco-DurántezDepartment of Medical Oncology, Hospital Universitario Central de Asturias, ISPA, 33011 Oviedo, Spain.
Luka Mihic-GóngoraDepartment of Medical Oncology, Hospital Universitario Central de Asturias, ISPA, 33011 Oviedo, Spain.
Sara Coca-MembribesDepartment of Medical Oncology, Hospital Universitario de Canarias, 38320 Tenerife, Spain.
Rocío Galán-MoralDepartment of Medical Oncology, Hospital General Universitario de Ciudad Real, 13005 Madrid, Spain.
Ana Fernández-MontesDepartment of Medical Oncology, Complejo Hospitalario Universitario de Ourense, 32005 Ourense, Spain.ORCID 0000-0003-4630-5830
Oscar A Castillo-TrujilloDepartment of Medical Oncology, Hospital Universitario Central de Asturias, ISPA, 33011 Oviedo, Spain.ORCID 0000-0001-7479-8658
Elena SorribesFaculty of Psychology, University of Barcelona, 08007 Barcelona, Spain.ORCID 0000-0001-8241-1273
Alicia QuilezDepartment of Medical Oncology, Hospital Can Misses, 07800 Eivissa, Spain.
Laura Puntí-BrunDepartment of Medical Oncology, Consorci Sanitari del Maresme, 08304 Mataró, Spain.
Paula Jiménez-FonsecaDepartment of Medical Oncology, Hospital Universitario Central de Asturias, ISPA, 33011 Oviedo, Spain.ORCID 0000-0003-4592-3813
Caterina CalderonFaculty of Psychology, University of Barcelona, 08007 Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The therapeutic alliance is an important factor in successful cancer treatment, particularly for those with advanced cancer. This study aims to determine how the therapeutic alliance relates to prognostic preferences and satisfaction with the physician and medical care among patients with advanced cancer. We conducted a cross-sectional study to explore the therapeutic relationship, trust, satisfaction with healthcare, and prognostic preferences among 946 patients with advanced cancer at 15 tertiary hospitals in Spain. Participants completed questionnaires with self-reported measures. Most were male, aged > 65 years, with bronchopulmonary (29%) or colorectal (16%) tumors and metastatic disease at diagnosis. Results revealed that 84% of patients had a good therapeutic alliance. Collaborative and affective bond was positively associated with a preference to know the prognosis and satisfaction with care and decision. There was no difference in a therapeutic alliance based on clinical or sociodemographic factors. The therapeutic alliance between patient and physician is essential for successful treatment outcomes and better overall satisfaction. Therefore, it is vital for healthcare providers to focus on establishing and maintaining a strong relationship with their patients. To achieve this, transparency and care should be prioritized, as well as respect for the preferences of patients regarding the prognosis of their illness.

Indexed as

NeoplasmsTherapeutic AllianceCross-Sectional StudiesFemaleHumansMaleSpainTreatment Outcomeadvanced canceralliance therapeuticcommunicationprognosissatisfaction

Identifiers

PMID37185386
PMCPMC10137084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.